COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges

Hyperactivation of immune responses resulting in excessive release of pro-inflammatory mediators in alveoli/lung structures is the principal pathological feature of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The cytokine hyperactivatio...

Full description

Bibliographic Details
Main Authors: Saikat Dewanjee, Ramesh Kandimalla, Rajkumar Singh Kalra, Chandrasekhar Valupadas, Jayalakshmi Vallamkondu, Viswakalyan Kolli, Sarbani Dey Ray, Arubala P. Reddy, P. Hemachandra Reddy
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
ACE
ACE2
anti-rheumatic drugs
COVID-19
cytokine storm
immune response
Online Access:https://www.mdpi.com/2073-4409/10/12/3291

Internet

https://www.mdpi.com/2073-4409/10/12/3291

Similar Items